Patients' costs and cost-effectiveness of tuberculosis treatment in DOTS and non-DOTS facilities in Rio de Janeiro, Brazil.
about
Directly observed therapy for treating tuberculosisFinancial burden for tuberculosis patients in low- and middle-income countries: a systematic reviewClinical treatment outcomes of tuberculosis treated with the basic regimen recommended by the Brazilian National Ministry of Health using fixed-dose combination tablets in the greater metropolitan area of Goiânia, BrazilThe Effectiveness of Family-Based DOTS versus Professional-Family Mix DOTS in Treating Smears Positive TuberculosisAdherence to self-administered tuberculosis treatment in a high HIV-prevalence setting: a cross-sectional survey in Homa Bay, Kenya.A meta-analysis of self-administered vs directly observed therapy effect on microbiologic failure, relapse, and acquired drug resistance in tuberculosis patientsCost-effectiveness of Quantiferon®-TB Gold-in-Tube versus tuberculin skin testing for contact screening and treatment of latent tuberculosis infection in Brazil.Smear plus Detect-TB for a sensitive diagnosis of pulmonary tuberculosis: a cost-effectiveness analysis in an incarcerated population.Modeling the impact of tuberculosis interventions on epidemiologic outcomes and health system costs.Shortened first-line TB treatment in Brazil: potential cost savings for patients and health services.Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review.Does directly observed therapy improve tuberculosis treatment? More evidence is needed to guide tuberculosis policy.Direct Observation of Treatment Provided by a Family Member as Compared to Non-Family Member among Children with New Tuberculosis: A Pragmatic, Non-Inferiority, Cluster-Randomized Trial in Gujarat, India.Ultra-short-course chemotherapy for spinal tuberculosis: five years of observation.Cost-effectiveness of novel first-line treatment regimens for tuberculosis.Comparison of two cash transfer strategies to prevent catastrophic costs for poor tuberculosis-affected households in low- and middle-income countries: An economic modelling study.Predictors of tuberculosis treatment outcomes.Applying optimization algorithms to tuberculosis antibiotic treatment regimens.Genetic interaction between NAT2, GSTM1, GSTT1, CYP2E1, and environmental factors is associated with adverse reactions to anti-tuberculosis drugs.Impact of Clofazimine Dosing on Treatment-Shortening of the First-Line Regimen in a Mouse Model of Tuberculosis.Is the directly observed therapy short course (DOTS) an effective strategy for tuberculosis control in a developing country?
P2860
Q24187767-FCF5050D-BD4C-48B9-8AC2-A5E8DF16633AQ33692632-79137599-3550-4711-B50E-B0B7854E4062Q33823893-0EBBE5E3-1769-45BE-AEDE-D7A105A96031Q34003342-D65268B2-8791-4A36-BD23-2E9A47E56283Q34199723-73B0BDC8-E239-4371-A896-2DB5926C3C32Q34332805-DFC9E462-6C8E-4BF3-84FC-C09ABAD49A30Q34672436-11569FEC-0D0E-4C50-9E89-E1BFCCB5B024Q34986773-A60E0F86-C7D5-4871-A06F-FD9D1D063E44Q35105344-9E17CD26-E1CC-4B89-A4D2-144C35882313Q35901882-51A75A7E-4104-46FB-B8B0-E3AB3B0160B4Q36024119-9BA6CE5C-89C7-4735-8810-41A651B2786CQ36156704-203F6A62-B890-415B-98F0-0120B46E1B2BQ36552054-EC53CE59-ABD2-4E63-9658-20FA6D6E66B9Q36564239-896549A4-C02B-4EA9-A337-37E01E90D9DEQ37351675-4B768D5A-EC4B-4497-AF3E-225A79E0153EQ43924045-7103AF15-570B-4EA6-9214-642925E295D5Q44213840-B2A62583-82DC-425D-A2F6-E485E622CC0DQ47220472-C306FD3F-EBA6-4980-ABBC-5FA06AC23599Q51325880-4E298059-9F88-4097-B7B3-E1DE023F00FAQ53686602-FC758CD6-DB4E-4151-BE55-3D22DB1799DFQ57950088-D9C044A3-99C3-4184-847B-C870934D4C28
P2860
Patients' costs and cost-effectiveness of tuberculosis treatment in DOTS and non-DOTS facilities in Rio de Janeiro, Brazil.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Patients' costs and cost-effec ...... ies in Rio de Janeiro, Brazil.
@ast
Patients' costs and cost-effec ...... ies in Rio de Janeiro, Brazil.
@en
type
label
Patients' costs and cost-effec ...... ies in Rio de Janeiro, Brazil.
@ast
Patients' costs and cost-effec ...... ies in Rio de Janeiro, Brazil.
@en
prefLabel
Patients' costs and cost-effec ...... ies in Rio de Janeiro, Brazil.
@ast
Patients' costs and cost-effec ...... ies in Rio de Janeiro, Brazil.
@en
P2093
P2860
P1433
P1476
Patients' costs and cost-effec ...... ies in Rio de Janeiro, Brazil.
@en
P2093
Analia Zuleika de Castro
Anete Trajman
Marcia Pinto
Olivia Oxlade
Paula Monteiro
Ricardo Steffen
P2860
P304
P356
10.1371/JOURNAL.PONE.0014014
P407
P50
P577
2010-11-17T00:00:00Z